#begin document (en_2794.txt); part 000
en_2794.txt	0	0	Pharmaceutical	NNP	(TOP(NP*	-	-	-	-	*	-
en_2794.txt	0	1	Myths	NNPS	*))	-	-	-	-	*	-

en_2794.txt	0	0	Drug	NN	(TOP(S(NP*	-	-	-	-	*	(0
en_2794.txt	0	1	companies	NNS	*)	-	-	-	-	*	0)
en_2794.txt	0	2	want	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	3	us	PRP	(S(NP*)	-	-	-	-	*	(0)
en_2794.txt	0	4	to	TO	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	believe	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	7	soaring	VBG	(S(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	8	prices	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	10	prescription	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	11	drugs	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	12	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	13	necessary	JJ	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	14	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	15	cover	VB	(VP(VP*	-	-	-	-	*	-
en_2794.txt	0	16	their	PRP$	(NP*	-	-	-	-	*	(0)
en_2794.txt	0	17	research	NN	*	-	-	-	-	*	-
en_2794.txt	0	18	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	19	development	NN	*))	-	-	-	-	*	-
en_2794.txt	0	20	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_2794.txt	0	21	R	NNP	(NP*	-	-	-	-	*	-
en_2794.txt	0	22	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	23	D	NNP	*)	-	-	-	-	*	-
en_2794.txt	0	24	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_2794.txt	0	25	costs	NNS	(NP*)))))	-	-	-	-	*	-
en_2794.txt	0	26	–	SYM	(SBAR(X*)	-	-	-	-	*	-
en_2794.txt	0	27	a	DT	(S(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	28	claim	NN	*)	-	-	-	-	*	-
en_2794.txt	0	29	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	30	implies	VBZ	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	31	that	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_2794.txt	0	32	they	PRP	(S(NP*)	-	-	-	-	*	(0)
en_2794.txt	0	33	spend	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	34	most	JJS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	35	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	36	their	PRP$	(NP*	-	-	-	-	*	(0)
en_2794.txt	0	37	money	NN	*)))	-	-	-	-	*	-
en_2794.txt	0	38	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	39	R	NNP	(NP*	-	-	-	-	*	(1
en_2794.txt	0	40	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	41	D	NNP	*)))))	-	-	-	-	*	1)
en_2794.txt	0	42	,	,	*	-	-	-	-	*	-
en_2794.txt	0	43	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	44	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	45	after	IN	(S(SBAR*	-	-	-	-	*	-
en_2794.txt	0	46	they	PRP	(S(NP*)	-	-	-	-	*	(0)
en_2794.txt	0	47	pay	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	48	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	49	it	PRP	(NP*)))))	-	-	-	-	*	-
en_2794.txt	0	50	,	,	*	-	-	-	-	*	-
en_2794.txt	0	51	they	PRP	(NP*)	-	-	-	-	*	(0)
en_2794.txt	0	52	have	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	53	only	RB	(NP*	-	-	-	-	*	-
en_2794.txt	0	54	modest	JJ	*	-	-	-	-	*	-
en_2794.txt	0	55	profits	NNS	*)))))))))	-	-	-	-	*	-
en_2794.txt	0	56	left	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	57	over	RP	(PRT*)))))))))))	-	-	-	-	*	-
en_2794.txt	0	58	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Curtailing	NN	(TOP(S(NP*	-	-	-	-	*	-
en_2794.txt	0	1	prices	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	2	,	,	(PRN*	-	-	-	-	*	-
en_2794.txt	0	3	they	PRP	(S(NP*)	-	-	-	-	*	(0)
en_2794.txt	0	4	say	VBP	(VP*))	-	-	-	-	*	-
en_2794.txt	0	5	,	,	*)	-	-	-	-	*	-
en_2794.txt	0	6	would	MD	(VP*	-	-	-	-	*	-
en_2794.txt	0	7	choke	VB	(VP(VP*	-	-	-	-	*	-
en_2794.txt	0	8	off	RP	(PRT*)	-	-	-	-	*	-
en_2794.txt	0	9	R	NNP	(NP*	-	-	-	-	*	(1
en_2794.txt	0	10	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	11	D	NNP	*))	-	-	-	-	*	1)
en_2794.txt	0	12	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	13	stifle	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	14	innovation	NN	(NP*))))	-	-	-	-	*	-
en_2794.txt	0	15	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_2794.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	2	real	JJ	*	-	-	-	-	*	-
en_2794.txt	0	3	story	NN	*)	-	-	-	-	*	-
en_2794.txt	0	4	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	very	RB	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	6	different	JJ	*))	-	-	-	-	*	-
en_2794.txt	0	7	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Big	JJ	(TOP(S(NP*	-	-	-	-	*	(2
en_2794.txt	0	1	drug	NN	*	-	-	-	-	*	-
en_2794.txt	0	2	companies	NNS	*)	-	-	-	-	*	2)
en_2794.txt	0	3	actually	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	4	spend	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	relatively	RB	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	6	little	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	7	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	8	R	NNP	(NP*	-	-	-	-	*	(1
en_2794.txt	0	9	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	10	D	NNP	*)))	-	-	-	-	*	1)
en_2794.txt	0	11	–	SYM	(X*)	-	-	-	-	*	-
en_2794.txt	0	12	far	RB	(ADVP(ADVP*	-	-	-	-	*	-
en_2794.txt	0	13	less	RBR	*)	-	-	-	-	*	-
en_2794.txt	0	14	than	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	15	they	PRP	(S(NP*)	-	-	-	-	*	(2)
en_2794.txt	0	16	spend	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	17	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	18	marketing	NN	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	19	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	20	administration	NN	*)	-	-	-	-	*	-
en_2794.txt	0	21	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	22	even	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_2794.txt	0	23	less	JJR	*)	-	-	-	-	*	-
en_2794.txt	0	24	than	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	25	what	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	26	they	PRP	(S(NP*)	-	-	-	-	*	(2)
en_2794.txt	0	27	have	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	28	left	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	29	over	RP	(PRT*)	-	-	-	-	*	-
en_2794.txt	0	30	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	31	profits	NNS	(NP*)))))))))))))))	-	-	-	-	*	-
en_2794.txt	0	32	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	2002	CD	(NP*))	-	-	-	-	*	-
en_2794.txt	0	2	,	,	*	-	-	-	-	*	-
en_2794.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	4	example	NN	(NP*))	-	-	-	-	*	-
en_2794.txt	0	5	,	,	*	-	-	-	-	*	-
en_2794.txt	0	6	the	DT	(NP*	-	-	-	-	*	(3
en_2794.txt	0	7	top	JJ	*	-	-	-	-	*	-
en_2794.txt	0	8	ten	JJ	*	-	-	-	-	*	-
en_2794.txt	0	9	American	JJ	*	-	-	-	-	*	-
en_2794.txt	0	10	drug	NN	*	-	-	-	-	*	-
en_2794.txt	0	11	companies	NNS	*)	-	-	-	-	*	3)
en_2794.txt	0	12	had	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	13	sales	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	15	$	$	(NP(QP*	-	-	-	-	*	-
en_2794.txt	0	16	217	CD	*	-	-	-	-	*	-
en_2794.txt	0	17	billion	CD	*)))))	-	-	-	-	*	-
en_2794.txt	0	18	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	According	VBG	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	2	their	PRP$	(NP*	-	-	-	-	*	(3)
en_2794.txt	0	3	own	JJ	*	-	-	-	-	*	-
en_2794.txt	0	4	figures	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	5	,	,	*	-	-	-	-	*	-
en_2794.txt	0	6	they	PRP	(NP*)	-	-	-	-	*	(3)
en_2794.txt	0	7	spent	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	8	14	CD	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	9	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	11	sales	NNS	(NP*	-	-	-	-	*	-
en_2794.txt	0	12	revenues	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	13	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	14	R	NN	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	15	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	16	D.	NNP	(NP(SBAR*	-	-	-	-	*	-
en_2794.txt	0	17	But	CC	(S*	-	-	-	-	*	-
en_2794.txt	0	18	they	PRP	(NP*)	-	-	-	-	*	(3)
en_2794.txt	0	19	spent	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	20	over	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	21	twice	RB	(ADVP*	-	-	-	-	*	-
en_2794.txt	0	22	as	RB	*	-	-	-	-	*	-
en_2794.txt	0	23	much	JJ	*))))	-	-	-	-	*	-
en_2794.txt	0	24	,	,	*	-	-	-	-	*	-
en_2794.txt	0	25	a	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	26	whopping	JJ	*	-	-	-	-	*	-
en_2794.txt	0	27	31	CD	*	-	-	-	-	*	-
en_2794.txt	0	28	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	29	,	,	*	-	-	-	-	*	-
en_2794.txt	0	30	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	31	marketing	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	32	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	33	administration	NN	*))))))	-	-	-	-	*	-
en_2794.txt	0	34	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	And	CC	(TOP(S*	-	-	-	-	*	-
en_2794.txt	0	1	they	PRP	(NP*)	-	-	-	-	*	(3)
en_2794.txt	0	2	had	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	3	17	CD	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	4	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	5	left	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	6	over	RP	(PRT*)	-	-	-	-	*	-
en_2794.txt	0	7	as	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	8	profits	NNS	(NP*)))))	-	-	-	-	*	-
en_2794.txt	0	9	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Most	JJS	(TOP(S(S(NP*	-	-	-	-	*	(4
en_2794.txt	0	1	drug	NN	*	-	-	-	-	*	-
en_2794.txt	0	2	companies	NNS	*)	-	-	-	-	*	4)
en_2794.txt	0	3	lump	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	4	marketing	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	5	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	6	administration	NN	*)	-	-	-	-	*	-
en_2794.txt	0	7	together	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	9	their	PRP$	(NP*	-	-	-	-	*	(4)
en_2794.txt	0	10	annual	JJ	*	-	-	-	-	*	-
en_2794.txt	0	11	reports	NNS	*))))	-	-	-	-	*	-
en_2794.txt	0	12	,	,	*	-	-	-	-	*	-
en_2794.txt	0	13	but	CC	*	-	-	-	-	*	-
en_2794.txt	0	14	one	PRP	(S(NP*)	-	-	-	-	*	-
en_2794.txt	0	15	reported	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	16	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	17	85	CD	(S(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	18	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	20	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	21	total	NN	*)))	-	-	-	-	*	-
en_2794.txt	0	22	went	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	23	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	24	marketing	NN	(NP*)))))))	-	-	-	-	*	-
en_2794.txt	0	25	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Assuming	VBG	(TOP(S(S(VP*	-	-	-	-	*	-
en_2794.txt	0	1	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	2	the	DT	(S(NP*	-	-	-	-	*	(5
en_2794.txt	0	3	figure	NN	*)	-	-	-	-	*	5)
en_2794.txt	0	4	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	roughly	RB	*	-	-	-	-	*	-
en_2794.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	7	same	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	8	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	9	the	DT	(NP*	-	-	-	-	*	(3
en_2794.txt	0	10	other	JJ	*	-	-	-	-	*	-
en_2794.txt	0	11	big	JJ	*	-	-	-	-	*	-
en_2794.txt	0	12	companies	NNS	*))	-	-	-	-	*	3)
en_2794.txt	0	13	–	SYM	(X*)))))))	-	-	-	-	*	-
en_2794.txt	0	14	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	15	there	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	16	'	''	*	-	-	-	-	*	-
en_2794.txt	0	17	s	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	18	reason	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	19	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	20	think	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	21	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	22	it	PRP	(S(NP*)	-	-	-	-	*	(5)
en_2794.txt	0	23	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	24	–	SYM	(SBAR(X*)	-	-	-	-	*	-
en_2794.txt	0	25	then	RB	(S(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	26	they	PRP	(NP*)	-	-	-	-	*	(3)
en_2794.txt	0	27	spent	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	28	nearly	RB	(ADVP(QP*	-	-	-	-	*	-
en_2794.txt	0	29	twice	RB	*)	-	-	-	-	*	-
en_2794.txt	0	30	as	RB	*	-	-	-	-	*	-
en_2794.txt	0	31	much	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	32	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	33	marketing	NN	(NP*)))))	-	-	-	-	*	-
en_2794.txt	0	34	alone	RB	(ADVP(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	35	as	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	36	they	PRP	(S(NP*)	-	-	-	-	*	(3)
en_2794.txt	0	37	did	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	38	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	39	R	NNP	(NP*	-	-	-	-	*	(1
en_2794.txt	0	40	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	41	D	NNP	*))))))))))))))	-	-	-	-	*	1)
en_2794.txt	0	42	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	its	PRP$	(NP*	-	-	-	-	*	(5)
en_2794.txt	0	2	public	JJ	*	-	-	-	-	*	-
en_2794.txt	0	3	pronouncements	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	4	,	,	*	-	-	-	-	*	-
en_2794.txt	0	5	the	DT	(NP*	-	-	-	-	*	(6
en_2794.txt	0	6	industry	NN	*)	-	-	-	-	*	6)
en_2794.txt	0	7	denies	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	8	this	DT	(NP*)	-	-	-	-	*	-
en_2794.txt	0	9	by	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	10	counting	VBG	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	11	just	RB	(NP(QP*	-	-	-	-	*	-
en_2794.txt	0	12	four	CD	*)	-	-	-	-	*	-
en_2794.txt	0	13	specific	JJ	*	-	-	-	-	*	-
en_2794.txt	0	14	activities	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	15	as	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	16	marketing	NN	(S(NP*	-	-	-	-	*	-
en_2794.txt	0	17	–	NN	*	-	-	-	-	*	-
en_2794.txt	0	18	sales	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	19	visits	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	20	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	21	doctors	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	22	,	,	*	-	-	-	-	*	-
en_2794.txt	0	23	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	24	value	NN	*)	-	-	-	-	*	-
en_2794.txt	0	25	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	26	free	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	27	samples	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	28	,	,	*	-	-	-	-	*	-
en_2794.txt	0	29	direct-to-consumer	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	30	advertisements	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	31	,	,	*	-	-	-	-	*	-
en_2794.txt	0	32	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	33	advertisements	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	34	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	35	medical	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	36	journals	NNS	*))))))))))))	-	-	-	-	*	-
en_2794.txt	0	37	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_2794.txt	0	1	,	,	*	-	-	-	-	*	-
en_2794.txt	0	2	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	3	fact	NN	(NP*))	-	-	-	-	*	-
en_2794.txt	0	4	,	,	*	-	-	-	-	*	-
en_2794.txt	0	5	marketing	NN	(NP*	-	-	-	-	*	(7
en_2794.txt	0	6	budgets	NNS	*)	-	-	-	-	*	7)
en_2794.txt	0	7	cover	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	8	a	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	9	lot	NN	*)	-	-	-	-	*	-
en_2794.txt	0	10	more	RBR	(PP*	-	-	-	-	*	-
en_2794.txt	0	11	than	IN	*	-	-	-	-	*	-
en_2794.txt	0	12	this	DT	(NP*)	-	-	-	-	*	-
en_2794.txt	0	13	,	,	*	-	-	-	-	*	-
en_2794.txt	0	14	most	RBS	(ADVP(ADVP*	-	-	-	-	*	-
en_2794.txt	0	15	importantly	RB	*)	-	-	-	-	*	-
en_2794.txt	0	16	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	17	``	``	*	-	-	-	-	*	-
en_2794.txt	0	18	education	NN	*	-	-	-	-	*	-
en_2794.txt	0	19	''	''	*))	-	-	-	-	*	-
en_2794.txt	0	20	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	21	doctors	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	22	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_2794.txt	0	23	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	24	teaches	VBZ	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	25	them	PRP	(NP*)	-	-	-	-	*	(7)
en_2794.txt	0	26	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	27	prescribe	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	28	more	JJR	(NP*	-	-	-	-	*	-
en_2794.txt	0	29	drugs	NNS	*)))))))	-	-	-	-	*	-
en_2794.txt	0	30	-RRB-	-RRB-	*))))))	-	-	-	-	*	-
en_2794.txt	0	31	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	And	CC	(TOP(FRAG*	-	-	-	-	*	-
en_2794.txt	0	1	what	WP	*	-	-	-	-	*	-
en_2794.txt	0	2	about	IN	*	-	-	-	-	*	-
en_2794.txt	0	3	profits	NNS	(NP*)	-	-	-	-	*	-
en_2794.txt	0	4	?	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	many	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	2	years	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	3	,	,	*	-	-	-	-	*	-
en_2794.txt	0	4	drug	NN	(NP(NP*	-	-	-	-	*	(8
en_2794.txt	0	5	companies	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	7	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	8	United	NNP	*	-	-	-	-	*	-
en_2794.txt	0	9	States	NNPS	*)))	-	-	-	-	*	8)
en_2794.txt	0	10	have	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	11	had	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	12	higher	JJR	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	13	profits	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	14	than	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	15	any	DT	(S(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	16	other	JJ	*	-	-	-	-	*	-
en_2794.txt	0	17	industry	NN	*)	-	-	-	-	*	-
en_2794.txt	0	18	–	SYM	(X(X*)	-	-	-	-	*	-
en_2794.txt	0	19	after	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	20	they	PRP	(NP*)))	-	-	-	-	*	(8)
en_2794.txt	0	21	'	''	*)	-	-	-	-	*	-
en_2794.txt	0	22	ve	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	23	paid	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	24	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	25	R	NNP	(NP(NP*	-	-	-	-	*	(1
en_2794.txt	0	26	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	27	D	NNP	*)	-	-	-	-	*	1)
en_2794.txt	0	28	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	29	all	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	30	their	PRP$	*	-	-	-	-	*	(8)
en_2794.txt	0	31	other	JJ	*	-	-	-	-	*	-
en_2794.txt	0	32	expenses	NNS	*))))))))))	-	-	-	-	*	-
en_2794.txt	0	33	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Compare	VB	(TOP(S(S(VP*	-	-	-	-	*	-
en_2794.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	2	17	CD	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	3	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	4	profit	NN	*	-	-	-	-	*	-
en_2794.txt	0	5	margin	NN	*)	-	-	-	-	*	-
en_2794.txt	0	6	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	7	the	DT	(NP*	-	-	-	-	*	(3
en_2794.txt	0	8	top	JJ	*	-	-	-	-	*	-
en_2794.txt	0	9	ten	JJ	*	-	-	-	-	*	-
en_2794.txt	0	10	American	JJ	*	-	-	-	-	*	-
en_2794.txt	0	11	drug	NN	*	-	-	-	-	*	-
en_2794.txt	0	12	companies	NNS	*))	-	-	-	-	*	3)
en_2794.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	14	2002	CD	(NP*)))	-	-	-	-	*	-
en_2794.txt	0	15	with	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	16	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	17	median	NN	*)	-	-	-	-	*	-
en_2794.txt	0	18	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	19	only	RB	(NP(QP*	-	-	-	-	*	-
en_2794.txt	0	20	3.1	CD	*)	-	-	-	-	*	-
en_2794.txt	0	21	%	NN	*))	-	-	-	-	*	-
en_2794.txt	0	22	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	23	all	DT	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	25	America	NNP	(NP*))))))))	-	-	-	-	*	-
en_2794.txt	0	26	'	:	*	-	-	-	-	*	-
en_2794.txt	0	27	s	VBZ	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	28	``	``	(NP*	-	-	-	-	*	-
en_2794.txt	0	29	Fortune	NNP	(NP*	-	-	-	-	*	-
en_2794.txt	0	30	500	CD	*)	-	-	-	-	*	-
en_2794.txt	0	31	''	''	*	-	-	-	-	*	-
en_2794.txt	0	32	industries	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	33	that	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	34	year	NN	*)))	-	-	-	-	*	-
en_2794.txt	0	35	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	In	IN	(TOP(S(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	2003	CD	(NP*))	-	-	-	-	*	-
en_2794.txt	0	2	,	,	*	-	-	-	-	*	-
en_2794.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	4	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	5	first	JJ	*	-	-	-	-	*	-
en_2794.txt	0	6	time	NN	*))	-	-	-	-	*	-
en_2794.txt	0	7	,	,	*	-	-	-	-	*	-
en_2794.txt	0	8	the	DT	(NP*	-	-	-	-	*	(6
en_2794.txt	0	9	industry	NN	*)	-	-	-	-	*	6)
en_2794.txt	0	10	fell	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	11	slightly	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	12	from	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	13	first	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	14	place	NN	*))	-	-	-	-	*	-
en_2794.txt	0	15	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	16	third	JJ	(NP*))	-	-	-	-	*	-
en_2794.txt	0	17	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	18	terms	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	20	profitability	NN	(NP*))))))	-	-	-	-	*	-
en_2794.txt	0	21	,	,	*	-	-	-	-	*	-
en_2794.txt	0	22	but	CC	*	-	-	-	-	*	-
en_2794.txt	0	23	its	PRP$	(S(NP*	-	-	-	-	*	(6)
en_2794.txt	0	24	profits	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	25	were	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	26	still	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	27	well	RB	(PP(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	28	above	IN	*	-	-	-	-	*	-
en_2794.txt	0	29	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	30	median	NN	*))))	-	-	-	-	*	-
en_2794.txt	0	31	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	1	recent	JJ	*	-	-	-	-	*	-
en_2794.txt	0	2	claim	NN	*)	-	-	-	-	*	-
en_2794.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	4	drug	NN	(S(NP*	-	-	-	-	*	(9
en_2794.txt	0	5	companies	NNS	*)	-	-	-	-	*	9)
en_2794.txt	0	6	spend	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	7	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	8	average	NN	(NP*))	-	-	-	-	*	-
en_2794.txt	0	9	$	$	(NP(QP*	-	-	-	-	*	-
en_2794.txt	0	10	802	CD	*	-	-	-	-	*	-
en_2794.txt	0	11	million	CD	*))	-	-	-	-	*	-
en_2794.txt	0	12	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	13	bring	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	14	each	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	15	new	JJ	*	-	-	-	-	*	-
en_2794.txt	0	16	drug	NN	*)	-	-	-	-	*	-
en_2794.txt	0	17	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	18	market	NN	(NP*)))))))))	-	-	-	-	*	-
en_2794.txt	0	19	is	VBZ	(VP(VP*	-	-	-	-	*	-
en_2794.txt	0	20	based	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	21	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	22	secret	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	23	,	,	*	-	-	-	-	*	-
en_2794.txt	0	24	proprietary	JJ	*	-	-	-	-	*	-
en_2794.txt	0	25	data	NNS	*))))	-	-	-	-	*	-
en_2794.txt	0	26	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	27	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	28	wildly	RB	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	29	inflated	JJ	*)))	-	-	-	-	*	-
en_2794.txt	0	30	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_2794.txt	0	1	,	,	*	-	-	-	-	*	-
en_2794.txt	0	2	whatever	WDT	(SBAR(WHADVP*)	-	-	-	-	*	-
en_2794.txt	0	3	they	PRP	(S(NP*)	-	-	-	-	*	(9)
en_2794.txt	0	4	spend	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	6	R	NNP	(NP*	-	-	-	-	*	(1
en_2794.txt	0	7	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	8	D	NNP	*)))))	-	-	-	-	*	1)
en_2794.txt	0	9	,	,	*	-	-	-	-	*	-
en_2794.txt	0	10	if	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	11	drug	NN	(S(NP*	-	-	-	-	*	(9
en_2794.txt	0	12	companies	NNS	*)	-	-	-	-	*	9)
en_2794.txt	0	13	spend	VBP	(VP(VP*	-	-	-	-	*	-
en_2794.txt	0	14	more	JJR	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	15	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	16	marketing	NN	(NP*))))	-	-	-	-	*	-
en_2794.txt	0	17	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	18	have	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	19	more	JJR	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	20	left	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	21	over	RP	(PRT*)	-	-	-	-	*	-
en_2794.txt	0	22	as	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	23	profits	NNS	(NP*))))))))	-	-	-	-	*	-
en_2794.txt	0	24	,	,	*	-	-	-	-	*	-
en_2794.txt	0	25	they	PRP	(NP*)	-	-	-	-	*	(9)
en_2794.txt	0	26	can	MD	(VP*	-	-	-	-	*	-
en_2794.txt	0	27	hardly	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	28	claim	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	29	that	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_2794.txt	0	30	high	JJ	(S(NP*	-	-	-	-	*	-
en_2794.txt	0	31	prices	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	32	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	33	necessary	JJ	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	34	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	35	cover	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	36	their	PRP$	(NP*	-	-	-	-	*	(1|(9)
en_2794.txt	0	37	R	NN	*))))))))	-	-	-	-	*	1)
en_2794.txt	0	38	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	39	D.	NNP	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	40	Instead	RB	(S(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	41	,	,	*	-	-	-	-	*	-
en_2794.txt	0	42	high	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	43	prices	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	44	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	45	necessary	JJ	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	46	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	47	cover	VB	(VP(VP*	-	-	-	-	*	-
en_2794.txt	0	48	their	PRP$	(NP*	-	-	-	-	*	(9)
en_2794.txt	0	49	stupendous	JJ	*	-	-	-	-	*	-
en_2794.txt	0	50	marketing	NN	*	-	-	-	-	*	-
en_2794.txt	0	51	expenditures	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	52	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	53	maintain	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	54	their	PRP$	(NP*	-	-	-	-	*	(9)
en_2794.txt	0	55	enormous	JJ	*	-	-	-	-	*	-
en_2794.txt	0	56	profits	NNS	*))))))))))))	-	-	-	-	*	-
en_2794.txt	0	57	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	There	EX	(TOP(S(S(NP*)	-	-	-	-	*	-
en_2794.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	2	now	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	3	some	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	4	pushback	NN	*)	-	-	-	-	*	-
en_2794.txt	0	5	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	6	prices	NNS	(NP*)))))	-	-	-	-	*	-
en_2794.txt	0	7	,	,	*	-	-	-	-	*	-
en_2794.txt	0	8	but	CC	*	-	-	-	-	*	-
en_2794.txt	0	9	drug	NN	(S(NP*	-	-	-	-	*	(9
en_2794.txt	0	10	companies	NNS	*)	-	-	-	-	*	9)
en_2794.txt	0	11	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	12	compensating	VBG	(VP*	-	-	-	-	*	-
en_2794.txt	0	13	by	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	14	convincing	VBG	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	15	more	JJR	(NP*	-	-	-	-	*	-
en_2794.txt	0	16	people	NNS	*))))	-	-	-	-	*	-
en_2794.txt	0	17	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	18	take	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	19	more	JJR	(NP*	-	-	-	-	*	-
en_2794.txt	0	20	drugs	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	22	dubious	JJ	(NP(ADJP*	-	-	-	-	*	-
en_2794.txt	0	23	or	CC	*	-	-	-	-	*	-
en_2794.txt	0	24	exaggerated	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	25	ailments	NNS	*)))))	-	-	-	-	*	-
en_2794.txt	0	26	,	,	*	-	-	-	-	*	-
en_2794.txt	0	27	thereby	RB	(S(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	28	increasing	VBG	(VP*	-	-	-	-	*	-
en_2794.txt	0	29	volume	NN	(NP*))))))	-	-	-	-	*	-
en_2794.txt	0	30	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	The	DT	(TOP(S(S(NP*	-	-	-	-	*	-
en_2794.txt	0	1	important	JJ	*	-	-	-	-	*	-
en_2794.txt	0	2	issue	NN	*)	-	-	-	-	*	-
en_2794.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	4	not	RB	*	-	-	-	-	*	-
en_2794.txt	0	5	how	WRB	(SBAR(WHNP*	-	-	-	-	*	-
en_2794.txt	0	6	much	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	7	drug	NN	(S(NP*	-	-	-	-	*	(9
en_2794.txt	0	8	companies	NNS	*)	-	-	-	-	*	9)
en_2794.txt	0	9	spend	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	10	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	11	R	NNP	(NP*	-	-	-	-	*	(1
en_2794.txt	0	12	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	13	D	NNP	*)))))))	-	-	-	-	*	1)
en_2794.txt	0	14	,	,	*	-	-	-	-	*	-
en_2794.txt	0	15	but	CC	*	-	-	-	-	*	-
en_2794.txt	0	16	whether	IN	(S(SBAR*	-	-	-	-	*	-
en_2794.txt	0	17	we	PRP	(S(NP*	-	-	-	-	*	(0)
en_2794.txt	0	18	consumers	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	19	get	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	20	our	PRP$	(NP*	-	-	-	-	*	(0)
en_2794.txt	0	21	money	NN	*)	-	-	-	-	*	-
en_2794.txt	0	22	'	''	*)))	-	-	-	-	*	-
en_2794.txt	0	23	s	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	24	worth	JJ	(ADJP*)))	-	-	-	-	*	-
en_2794.txt	0	25	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Remarkable	CC	(TOP(S*	-	-	-	-	*	-
en_2794.txt	0	1	as	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	2	it	PRP	(S(NP*)	-	-	-	-	*	-
en_2794.txt	0	3	seems	VBZ	(VP*)))	-	-	-	-	*	-
en_2794.txt	0	4	,	,	*	-	-	-	-	*	-
en_2794.txt	0	5	only	RB	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	6	a	DT	*	-	-	-	-	*	-
en_2794.txt	0	7	small	JJ	*	-	-	-	-	*	-
en_2794.txt	0	8	fraction	NN	*)	-	-	-	-	*	-
en_2794.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	10	drugs	NNS	(NP*)))	-	-	-	-	*	-
en_2794.txt	0	11	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	12	innovative	JJ	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	14	any	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	15	meaningful	JJ	*	-	-	-	-	*	-
en_2794.txt	0	16	sense	NN	*)	-	-	-	-	*	-
en_2794.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	18	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	19	word	NN	*))))))	-	-	-	-	*	-
en_2794.txt	0	20	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	2	six	CD	*	-	-	-	-	*	-
en_2794.txt	0	3	years	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	4	from	IN	(PP(PP(PP*	-	-	-	-	*	-
en_2794.txt	0	5	1998	CD	(NP*))	-	-	-	-	*	-
en_2794.txt	0	6	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	7	2003	CD	(NP*)))	-	-	-	-	*	-
en_2794.txt	0	8	,	,	*	-	-	-	-	*	-
en_2794.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	11	487	CD	*	-	-	-	-	*	-
en_2794.txt	0	12	drugs	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	13	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	14	entered	VBD	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	15	the	DT	(NP*	-	-	-	-	*	(10
en_2794.txt	0	16	market	NN	*)))))))))	-	-	-	-	*	10)
en_2794.txt	0	17	,	,	*	-	-	-	-	*	-
en_2794.txt	0	18	fully	RB	(NP(QP*	-	-	-	-	*	-
en_2794.txt	0	19	78	CD	*)	-	-	-	-	*	-
en_2794.txt	0	20	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	21	were	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	22	classified	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	23	by	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	24	the	DT	(NP*	-	-	-	-	*	(11
en_2794.txt	0	25	US	NNP	*	-	-	-	-	*	-
en_2794.txt	0	26	Food	NNP	*	-	-	-	-	*	-
en_2794.txt	0	27	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	28	Drug	NNP	*	-	-	-	-	*	-
en_2794.txt	0	29	Administration	NNP	*))	-	-	-	-	*	11)
en_2794.txt	0	30	as	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	31	likely	JJ	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	32	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	33	be	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	34	no	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_2794.txt	0	35	better	JJR	*)	-	-	-	-	*	-
en_2794.txt	0	36	than	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	37	drugs	NNS	(NP*)))	-	-	-	-	*	-
en_2794.txt	0	38	already	RB	(PP(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	39	on	IN	*	-	-	-	-	*	-
en_2794.txt	0	40	the	DT	(NP*	-	-	-	-	*	(10
en_2794.txt	0	41	market	NN	*)))))))))	-	-	-	-	*	10)
en_2794.txt	0	42	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Moreover	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	1	,	,	*	-	-	-	-	*	-
en_2794.txt	0	2	68	CD	(NP*	-	-	-	-	*	-
en_2794.txt	0	3	%	NN	*)	-	-	-	-	*	-
en_2794.txt	0	4	were	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	not	RB	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	6	even	RB	*	-	-	-	-	*	-
en_2794.txt	0	7	new	JJ	*	-	-	-	-	*	-
en_2794.txt	0	8	chemical	NN	*	-	-	-	-	*	-
en_2794.txt	0	9	compounds	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	10	,	,	*	-	-	-	-	*	-
en_2794.txt	0	11	but	CC	(CONJP*	-	-	-	-	*	-
en_2794.txt	0	12	just	RB	*)	-	-	-	-	*	-
en_2794.txt	0	13	old	JJ	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	14	drugs	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	15	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	16	new	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	17	forms	NNS	*	-	-	-	-	*	-
en_2794.txt	0	18	or	CC	*	-	-	-	-	*	-
en_2794.txt	0	19	combinations	NNS	*)))))	-	-	-	-	*	-
en_2794.txt	0	20	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	other	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	2	words	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	3	,	,	*	-	-	-	-	*	-
en_2794.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	5	major	JJ	*	-	-	-	-	*	-
en_2794.txt	0	6	output	NN	*)	-	-	-	-	*	-
en_2794.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	8	the	DT	(NP*	-	-	-	-	*	(6
en_2794.txt	0	9	industry	NN	*)))	-	-	-	-	*	6)
en_2794.txt	0	10	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	11	not	RB	*	-	-	-	-	*	-
en_2794.txt	0	12	important	JJ	(ADJP*)	-	-	-	-	*	-
en_2794.txt	0	13	new	JJ	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	14	drugs	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	15	,	,	*	-	-	-	-	*	-
en_2794.txt	0	16	but	CC	*	-	-	-	-	*	-
en_2794.txt	0	17	minor	JJ	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	18	variations	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	20	drugs	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	21	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	22	are	VBP	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	23	already	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	24	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	25	the	DT	(NP*	-	-	-	-	*	(10
en_2794.txt	0	26	market	NN	*))))))))	-	-	-	-	*	10)
en_2794.txt	0	27	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	28	called	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	29	copycat	NN	(S(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	30	or	CC	*	-	-	-	-	*	-
en_2794.txt	0	31	``	``	(NP*	-	-	-	-	*	-
en_2794.txt	0	32	me-too	JJ	*	-	-	-	-	*	-
en_2794.txt	0	33	''	''	*	-	-	-	-	*	-
en_2794.txt	0	34	drugs	NNS	*)))))))	-	-	-	-	*	-
en_2794.txt	0	35	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	example	NN	(NP*))	-	-	-	-	*	-
en_2794.txt	0	2	,	,	*	-	-	-	-	*	-
en_2794.txt	0	3	the	DT	(NP(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	4	top-selling	JJ	*	-	-	-	-	*	-
en_2794.txt	0	5	drug	NN	*)	-	-	-	-	*	-
en_2794.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	7	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	8	world	NN	*)))	-	-	-	-	*	-
en_2794.txt	0	9	,	,	*	-	-	-	-	*	-
en_2794.txt	0	10	Pfizer	NNP	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	11	'	POS	*)	-	-	-	-	*	-
en_2794.txt	0	12	s	NNP	*	-	-	-	-	*	-
en_2794.txt	0	13	Lipitor	NNP	*)	-	-	-	-	*	-
en_2794.txt	0	14	,	,	*)	-	-	-	-	*	-
en_2794.txt	0	15	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	16	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	17	fourth	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	18	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	19	six	CD	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	20	cholesterol-lowering	JJ	*	-	-	-	-	*	-
en_2794.txt	0	21	drugs	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	22	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	23	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	24	same	JJ	*	-	-	-	-	*	-
en_2794.txt	0	25	type	NN	*))))))	-	-	-	-	*	-
en_2794.txt	0	26	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_2794.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	2	now	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	3	whole	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	4	families	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	6	me-too	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	7	drugs	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	8	,	,	*	-	-	-	-	*	-
en_2794.txt	0	9	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	10	little	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	11	reason	NN	*	-	-	-	-	*	-
en_2794.txt	0	12	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	13	think	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	14	one	PRP	(SBAR(S(NP*)	-	-	-	-	*	-
en_2794.txt	0	15	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	16	better	JJR	(ADJP(ADJP*)	-	-	-	-	*	-
en_2794.txt	0	17	than	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	18	another	DT	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	19	at	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	20	comparable	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	21	doses	NNS	*))))))))))))))	-	-	-	-	*	-
en_2794.txt	0	22	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Far	RB	(TOP(S(PP(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	1	from	IN	*	-	-	-	-	*	-
en_2794.txt	0	2	being	VBG	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	3	a	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	4	model	NN	*)	-	-	-	-	*	-
en_2794.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	6	free	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	7	enterprise	NN	*))))))	-	-	-	-	*	-
en_2794.txt	0	8	,	,	*	-	-	-	-	*	-
en_2794.txt	0	9	the	DT	(NP*	-	-	-	-	*	(6
en_2794.txt	0	10	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2794.txt	0	11	industry	NN	*)	-	-	-	-	*	6)
en_2794.txt	0	12	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	13	utterly	RB	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	14	dependent	JJ	*	-	-	-	-	*	-
en_2794.txt	0	15	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	16	government-funded	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	17	research	NN	*)	-	-	-	-	*	-
en_2794.txt	0	18	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	19	government-granted	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	20	monopolies	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	22	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	23	form	NN	*)	-	-	-	-	*	-
en_2794.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	25	patents	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	26	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	27	exclusive	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	28	marketing	NN	*	-	-	-	-	*	-
en_2794.txt	0	29	rights	NNS	*)))))))))	-	-	-	-	*	-
en_2794.txt	0	30	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(12
en_2794.txt	0	1	few	JJ	*	-	-	-	-	*	-
en_2794.txt	0	2	innovative	JJ	*	-	-	-	-	*	-
en_2794.txt	0	3	drugs	NNS	*)	-	-	-	-	*	12)
en_2794.txt	0	4	usually	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	5	stem	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	6	from	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	7	publicly	RB	(NP(NP(ADJP*	-	-	-	-	*	-
en_2794.txt	0	8	funded	VBN	*)	-	-	-	-	*	-
en_2794.txt	0	9	research	NN	*)	-	-	-	-	*	-
en_2794.txt	0	10	done	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	11	at	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	12	government	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	13	or	CC	*	-	-	-	-	*	-
en_2794.txt	0	14	university	NN	*	-	-	-	-	*	-
en_2794.txt	0	15	labs	NNS	*))))))	-	-	-	-	*	-
en_2794.txt	0	16	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Even	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	1	among	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	2	related	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	3	me-too	JJ	*	-	-	-	-	*	-
en_2794.txt	0	4	drugs	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	5	,	,	*	-	-	-	-	*	-
en_2794.txt	0	6	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	7	original	NN	*)	-	-	-	-	*	-
en_2794.txt	0	8	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	9	usually	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	10	based	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	11	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	12	government-sponsored	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	13	work	NN	*))))	-	-	-	-	*	-
en_2794.txt	0	14	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	example	NN	(NP*))	-	-	-	-	*	-
en_2794.txt	0	2	,	,	*	-	-	-	-	*	-
en_2794.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	4	first	JJ	*)	-	-	-	-	*	-
en_2794.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	6	the	DT	(NP*	-	-	-	-	*	(12
en_2794.txt	0	7	Lipitor-type	JJ	*	-	-	-	-	*	-
en_2794.txt	0	8	drugs	NNS	*))	-	-	-	-	*	12)
en_2794.txt	0	9	,	,	*	-	-	-	-	*	-
en_2794.txt	0	10	Mevacor	NNP	(NP*)	-	-	-	-	*	-
en_2794.txt	0	11	,	,	*)	-	-	-	-	*	-
en_2794.txt	0	12	came	VBD	(VP(VP*	-	-	-	-	*	-
en_2794.txt	0	13	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	14	the	DT	(NP*	-	-	-	-	*	(10
en_2794.txt	0	15	market	NN	*))	-	-	-	-	*	10)
en_2794.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	17	1987	CD	(NP*)))	-	-	-	-	*	-
en_2794.txt	0	18	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	19	was	VBD	(VP*	-	-	-	-	*	-
en_2794.txt	0	20	based	VBN	(VP*	-	-	-	-	*	-
en_2794.txt	0	21	largely	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	22	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	23	university	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	24	research	NN	*)))))	-	-	-	-	*	-
en_2794.txt	0	25	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Most	JJS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	1	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	2	today	NN	(NP*))	-	-	-	-	*	-
en_2794.txt	0	3	'	''	*)	-	-	-	-	*	-
en_2794.txt	0	4	s	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	top-selling	JJ	(SBAR(S(NP*	-	-	-	-	*	-
en_2794.txt	0	6	drugs	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	7	have	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	8	progenitors	NNS	(NP(NP*)	-	-	-	-	*	-
en_2794.txt	0	9	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	10	date	VBP	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	11	back	RB	(ADVP(ADVP*	-	-	-	-	*	-
en_2794.txt	0	12	to	TO	(PP*	-	-	-	-	*	-
en_2794.txt	0	13	the	DT	(NP(NP*	-	-	-	-	*	-
en_2794.txt	0	14	1980	CD	*	-	-	-	-	*	-
en_2794.txt	0	15	'	POS	*)	-	-	-	-	*	-
en_2794.txt	0	16	s	NN	*)))	-	-	-	-	*	-
en_2794.txt	0	17	or	CC	*	-	-	-	-	*	-
en_2794.txt	0	18	even	RB	(ADVP*	-	-	-	-	*	-
en_2794.txt	0	19	earlier	RBR	*))))))))))	-	-	-	-	*	-
en_2794.txt	0	20	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_2794.txt	0	1	bottom	JJ	*	-	-	-	-	*	-
en_2794.txt	0	2	line	NN	*)	-	-	-	-	*	-
en_2794.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	4	that	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	5	,	,	*	-	-	-	-	*	-
en_2794.txt	0	6	despite	IN	(S(PP*	-	-	-	-	*	-
en_2794.txt	0	7	industry	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	8	rhetoric	NN	*))	-	-	-	-	*	-
en_2794.txt	0	9	,	,	*	-	-	-	-	*	-
en_2794.txt	0	10	drug	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	11	companies	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	12	are	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	13	growing	VBG	(VP*	-	-	-	-	*	-
en_2794.txt	0	14	less	RBR	(ADJP(ADVP*	-	-	-	-	*	-
en_2794.txt	0	15	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	16	less	RBR	*)	-	-	-	-	*	-
en_2794.txt	0	17	innovative	JJ	*))))))	-	-	-	-	*	-
en_2794.txt	0	18	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	They	PRP	(TOP(S(NP(NP*)	-	-	-	-	*	(13
en_2794.txt	0	1	'	:	(PRN*	-	-	-	-	*	-
en_2794.txt	0	2	re	VB	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	3	just	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	4	re-jiggering	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	the	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	6	same	JJ	*	-	-	-	-	*	-
en_2794.txt	0	7	old	JJ	*	-	-	-	-	*	-
en_2794.txt	0	8	drugs	NNS	*))	-	-	-	-	*	-
en_2794.txt	0	9	,	,	*	-	-	-	-	*	-
en_2794.txt	0	10	getting	VBG	(VP*	-	-	-	-	*	-
en_2794.txt	0	11	new	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	12	patents	NNS	*	-	-	-	-	*	-
en_2794.txt	0	13	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	14	exclusivity	NN	*))	-	-	-	-	*	-
en_2794.txt	0	15	,	,	*	-	-	-	-	*	-
en_2794.txt	0	16	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	17	relying	VBG	(VP*	-	-	-	-	*	-
en_2794.txt	0	18	on	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	19	their	PRP$	(NP*	-	-	-	-	*	(13)
en_2794.txt	0	20	marketing	NN	*	-	-	-	-	*	-
en_2794.txt	0	21	muscle	NN	*))	-	-	-	-	*	-
en_2794.txt	0	22	to	TO	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	23	convince	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	24	doctors	NNS	(NP*	-	-	-	-	*	-
en_2794.txt	0	25	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	26	patients	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	27	that	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	28	they	PRP	(NP*))))))))	-	-	-	-	*	(13)
en_2794.txt	0	29	'	:	*))	-	-	-	-	*	13)
en_2794.txt	0	30	re	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	31	producing	VBG	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	32	medical	JJ	(NP*	-	-	-	-	*	-
en_2794.txt	0	33	miracles	NNS	*))))	-	-	-	-	*	-
en_2794.txt	0	34	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Every	DT	(TOP(S(NP*	-	-	-	-	*	-
en_2794.txt	0	1	advanced	JJ	*	-	-	-	-	*	-
en_2794.txt	0	2	country	NN	*)	-	-	-	-	*	-
en_2794.txt	0	3	regulates	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	4	prescription	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	5	drug	NN	*	-	-	-	-	*	-
en_2794.txt	0	6	prices	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	8	some	DT	(NP*	-	-	-	-	*	-
en_2794.txt	0	9	way	NN	*)))	-	-	-	-	*	-
en_2794.txt	0	10	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	Even	RB	(TOP(S(PP*	-	-	-	-	*	-
en_2794.txt	0	1	in	IN	*	-	-	-	-	*	-
en_2794.txt	0	2	the	DT	(NP*	-	-	-	-	*	(11
en_2794.txt	0	3	US	NNP	*))	-	-	-	-	*	11)
en_2794.txt	0	4	,	,	*	-	-	-	-	*	-
en_2794.txt	0	5	Medicare	NNP	(NP*)	-	-	-	-	*	(14)
en_2794.txt	0	6	regulates	VBZ	(VP*	-	-	-	-	*	-
en_2794.txt	0	7	doctors	NNS	(NP(NP(NP*	-	-	-	-	*	(15
en_2794.txt	0	8	'	POS	*)	-	-	-	-	*	15)
en_2794.txt	0	9	fees	NNS	*)	-	-	-	-	*	-
en_2794.txt	0	10	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	11	hospital	NN	(NP*	-	-	-	-	*	-
en_2794.txt	0	12	payments	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	13	.	.	*))	-	-	-	-	*	-

en_2794.txt	0	0	So	IN	(TOP(S*	-	-	-	-	*	-
en_2794.txt	0	1	we	PRP	(NP*)	-	-	-	-	*	(0)
en_2794.txt	0	2	need	MD	(VP*	-	-	-	-	*	-
en_2794.txt	0	3	not	RB	*	-	-	-	-	*	-
en_2794.txt	0	4	worry	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	5	about	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	6	stifling	VBG	(S(VP*	-	-	-	-	*	-
en_2794.txt	0	7	innovative	JJ	(SBAR(SBAR(S(NP*	-	-	-	-	*	-
en_2794.txt	0	8	R	NN	(NX(NX*)	-	-	-	-	*	-
en_2794.txt	0	9	&	CC	*	-	-	-	-	*	-
en_2794.txt	0	10	D.	NNP	(NX*	-	-	-	-	*	-
en_2794.txt	0	11	Drug	NNP	*	-	-	-	-	*	-
en_2794.txt	0	12	companies	NNS	*)))	-	-	-	-	*	-
en_2794.txt	0	13	do	VBP	(VP*	-	-	-	-	*	-
en_2794.txt	0	14	much	RB	(ADJP*	-	-	-	-	*	-
en_2794.txt	0	15	less	JJR	*	-	-	-	-	*	-
en_2794.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_2794.txt	0	17	it	PRP	(NP*)))	-	-	-	-	*	(14)
en_2794.txt	0	18	than	IN	(SBAR*	-	-	-	-	*	-
en_2794.txt	0	19	they	PRP	(S(NP*)	-	-	-	-	*	(15)
en_2794.txt	0	20	claim	VBP	(VP*))))))	-	-	-	-	*	-
en_2794.txt	0	21	,	,	*	-	-	-	-	*	-
en_2794.txt	0	22	and	CC	*	-	-	-	-	*	-
en_2794.txt	0	23	what	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_2794.txt	0	24	they	PRP	(S(NP*)	-	-	-	-	*	(15)
en_2794.txt	0	25	do	VB	(VP*	-	-	-	-	*	-
en_2794.txt	0	26	they	PRP	(SBAR(S(NP*)	-	-	-	-	*	(15)
en_2794.txt	0	27	can	MD	(VP*	-	-	-	-	*	-
en_2794.txt	0	28	easily	RB	(ADVP*)	-	-	-	-	*	-
en_2794.txt	0	29	afford	VB	(VP*)))))))))))))	-	-	-	-	*	-
en_2794.txt	0	30	.	.	*))	-	-	-	-	*	-

#end document
